Otsuka’s Patrizia Carlevaro On The Massive Challenge Of Multi-Drug Resistant TB: An Interview With PharmAsia News (Part 2 of 2)

Otsuka hopes an effort to address the thorny problems of designing a treatment regime for multi-drug resistant tuberculosis can draw a united effort across companies, governments, patients and civil society groups to ensure a last chance cure that can take as long as two years to work remains effective.